Patents by Inventor Florence Faure

Florence Faure has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic composition containing antibodies to soluble polypeptide fractions of LAG-3 protein
    Patent number: 6143273
    Abstract: Soluble polypeptide fraction consisting of all or part of one at least one of the four immunoglobulin-type extracellular LAG-3 protein domains (amino acids 1-159, 160-230, 240-330 and 331-412 of the SEQ ID NO:1 sequence) or consisting of one peptide sequence derived from these domains by replacement, addition or deletion of one or more amino acids. The fraction of the invention has a specificity at least equal to that of LAG-3 in relation to its ligand.
    Type: Grant
    Filed: April 13, 1998
    Date of Patent: November 7, 2000
    Assignees: Institut Gustave Roussy, Institut National de la Sante et de la Recherche Medicale, Applied Research Systems ARS Holding N.V.
    Inventors: Florence Faure, Thierry Hercend, Bertrand Huard, Frederic Triebel
  • Soluble polypeptide fractions of the LAG-3 protein, production method, therapeutic composition, anti-idiotype antibodies
    Patent number: 5955300
    Abstract: Soluble polypeptide fraction consisting of all or part one at least of the four immunoglobulin-type extracellular LAG-3 protein domains (amino acids 1-159, 160-230, 240-330 and 331-412 of the SEQ ID NO:1 sequence) or consisting of one peptide sequence derived from these domains by replacement, addition or deletion of one or more amino acids. The fraction of the invention has a specificity at least equal to that of LAG-3 in relation to its ligand.
    Type: Grant
    Filed: December 24, 1996
    Date of Patent: September 21, 1999
    Assignees: Institut Gustave Roussy, Institut National de la Sante et de la Recherche Medicale (Inserm), Applied Research Systems ARS Holding N.V.
    Inventors: Florence Faure, Thierry Hercend, Bertrand Huard, Frederic Triebel
  • Soluble polypeptide fractions of the LAG-3 protein, production method, therapeutic composition, anti-idiotype antibodies
    Patent number: RE38313
    Abstract: Soluble polypeptide fraction consisting of all or part one of at least one of the four immunoglobulin-type extracellular LAG-3 protein domains (amino acids 1-159, 160-230 239, 240-330 and 331-412 of the SEQ ID NO:1 sequence) or consisting of one peptide sequence derived from these domains by replacement, addition or deletion of one or more amino acids. The fraction of the invention has a specificity at least equal to that of LAG-3 in relation to its ligand.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: November 11, 2003
    Assignees: Institut Gustave Roussy, Institut National de la Sante et de la Recherche Medicale (INSERM), Applied Research System ARS Holding N.V.
    Inventors: Florence Faure, Thierry Hercend, Bertrand Huard, Frédéric Triebel